StageZero Life Sciences Equity Warrants Exp 4th Dec 2023 SZLS"S-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 04/13/22 EDT
0.15UNCH (UNCH)
52 week range
0.10 - 0.34
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.15
  • 52 Week High0.34
  • 52 Week High Date06/03/21
  • 52 Week Low0.10
  • 52 Week Low Date02/16/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.15
  • 52 Week High0.34
  • 52 Week High Date06/03/21
  • 52 Week Low0.10
  • 52 Week Low Date02/16/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On StageZero Life Sciences Equity Warrants Exp 4th Dec 2023

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
StageZero Life Sciences Ltd. is a Canada-based company that is focused on developing and commercializing molecular diagnostic tests for early detection of cancer. The Company has developed Sentinel Principle platform technology, which determines biomarkers from whole blood. The Company offers ColonSentry product, which is a blood test to determine an individual’s current risk for having colorectal cancer. It offers Aristotle, a mRNA-based multi-cancer detection panel for...
James Howardtripp
Executive Chairman of the Board, Chief Executive Officer
Matthew Pietras CPA
Chief Financial Officer, Chief Operating Officer
Address
70 East Beaver Creek Rd, Unit 30
Richmond Hill, ON
L4B 3B2
Canada